By going through bankruptcy, the Irvine, CA-based company is expected to eliminate about $180 million of debt from its balance sheet. For the past few years, Endologix has struggled with regulatory issues tied to the Nellix EndoVascular Aneurysm Sealing System.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,